AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

Levofloxacin USP

10 registrations across 2 African markets— 8 active

Markets with Levofloxacin USP

Recent registrations

Brand / ProductMarketHolderStatusExpires
INFILE TABLETS ( Levofloxacin USP 500 mg )🇬🇭GhanaactiveDec 2026
INFILE TABLETS ( Levofloxacin USP 500 mg )🇬🇭GhanaactiveDec 2026
WELQUINE INFUSION (Each 100ml contains Levofloxacin USP 500mg)🇬🇭GhanaactiveDec 2026
INFILE TABLETS ( Levofloxacin USP 750 mg)🇬🇭GhanaactiveDec 2026
WELQUINE INFUSION (Each 100ml contains Levofloxacin USP 500mg)🇬🇭GhanaactiveDec 2026
INFILE TABLETS (Levofloxacin USP 500 mg )🇬🇭GhanaactiveDec 2026
INFILE TABLETS (Levofloxacin USP 500 mg )🇬🇭GhanaactiveDec 2026
INFILE TABLETS ( Levofloxacin USP 750 mg)🇬🇭GhanaactiveDec 2026
BIOMEGRACIN TABLETS
1 X 10
🇳🇬NigeriaBIOMEDICINE S.P.N.L NO. 16expiredFeb 2022
FLEXYLEVO TABLETS
TABLETS 1 X 10
🇳🇬NigeriaOMAK PHARM NIG LTD SUITE 1&2expiredOct 2021

Levofloxacin USP in Africa — Regulatory Overview

Levofloxacin USP is registered across 2 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, Nigeria. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 8 (80%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.